SOLENO THERAPEUTICS INC
SOLENO THERAPEUTICS INC
REDWOOD CITY, CA
Loading...
Price History
Market Data
| Market Cap | 2.73B |
| P/E Ratio | 195.98 |
| P/B Ratio | 6.07 |
| EPS | 0.27 |
| Dividend Yield | - |
| D/E Ratio | 0.25 |
| Current Ratio | 5.80 |
| Currency | USD |
Key Financial Metrics
-
Revenue
20.89M
Net Income
0.27
EPS (Diluted)
-31.41M
Free Cash Flow
Profitability
Gross Margin
-
Operating Margin
-
Net Profit Margin
-
EBITDA
11.94M
Returns & Efficiency
Return on Assets (ROA)
3.7%
Return on Equity (ROE)
4.6%
Dividend Yield
-
EPS
0.27
Financial Health
Total Assets
563.83M
Total Debt
49.86M
Debt to Equity
0.25x
Current Ratio
5.80
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| Industry | Chemicals & Allied Products |
| HQ | REDWOOD CITY, CA |
| Fiscal Year | 2025 |
Peers
LILLY ELI & CO
LLY
931.26B
P/E: --
ELI LILLY & CO
LLY
931.26B
P/E: --
543.83B
P/E: --
ABBVIE INC.
ABBV
365.53B
P/E: --
BEIGENE, LTD.
BEIGF
306.50B
P/E: 632.4
BEONE MEDICINES LTD.
BEIGF
306.50B
P/E: 632.4
281.00B
P/E: --
MERCK & CO. INC.
MRK
281.00B
P/E: --
Quick Links
Financial Statistics
Valuation
Market Cap$2.73B
P/E Ratio (TTM)196.0
Price to Book6.07
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin-
Operating Margin-
Net Margin-
ROE4.6%
ROA3.7%
Leverage & Liquidity
Debt to Equity0.25
Current Ratio5.80
Total Debt$49.86M
Total Assets$563.83M
Stockholders' Equity$450.12M
Income Statement (FY 2025)
Revenue-
Gross Profit-
Operating Income$9.41M
Net Income$20.89M
EPS (Diluted)$0.27
Cash Flow (FY 2025)
Free Cash Flow$-31.41M
Cash & Equivalents$70.11M
Revenue Growth-
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | 100 MARINE PARKWAY, SUITE 400 REDWOOD CITY, CA 94065 |
| Phone | 650-213-8444 |
| Incorporated | DE, US |
| EIN | 770523891 |
| Fiscal Year End | 1231 |
| Shares Outstanding | 51.62M |
| Stockholders' Equity | $450.12M |
| Cash & Equivalents | $70.11M |
Recent Filings
View All
10-K/A
Amended Annual Report
Amendment to previously filed annual report
Filed: 2026-04-30
Local
SC TO-T/A
SC TO-T/A Filing
SEC regulatory filing
Filed: 2026-04-29
Local
SC 14D9/A
SC 14D9/A Filing
SEC regulatory filing
Filed: 2026-04-28
Local
SC TO-T/A
SC TO-T/A Filing
SEC regulatory filing
Filed: 2026-04-28
Local
SC TO-T
SC TO-T Filing
SEC regulatory filing
Filed: 2026-04-20
Local
SC 14D9
SC 14D9 Filing
SEC regulatory filing
Filed: 2026-04-20
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-04-07
Local
SC TO-C
SC TO-C Filing
SEC regulatory filing
Filed: 2026-04-07
Local
SC14D9C
SC14D9C Filing
SEC regulatory filing
Filed: 2026-04-06
Local
SC TO-C
SC TO-C Filing
SEC regulatory filing
Filed: 2026-04-06
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-04-06
Local
SC TO-C
SC TO-C Filing
SEC regulatory filing
Filed: 2026-04-06
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-31
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-31
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-03-16
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | SOLENO THERAPEUTICS INC |
| Ticker | SLNO |
| Exchange | -- |
| Sector | Manufacturing |
| Industry | Chemicals & Allied Products |
| Headquarters | REDWOOD CITY, CA |
| Fiscal Year | 2025 |
Financial Summary
| Market Cap | 2.73B |
| Revenue | - |
| Net Income | 20.89M |
| P/E Ratio | 195.98 |
| EPS | 0.27 |
| Net Margin | - |
| ROE | 4.6% |
| Dividend Yield | - |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...